Mesa Laboratories (NASDAQ:MLAB – Get Free Report) is expected to be announcing its earnings results before the market opens on Monday, February 3rd. Analysts expect the company to announce earnings of $1.41 per share and revenue of $58,170.00 billion for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.
Mesa Laboratories (NASDAQ:MLAB – Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $1.81 EPS for the quarter, missing the consensus estimate of $1.95 by ($0.14). Mesa Laboratories had a negative net margin of 107.56% and a positive return on equity of 28.52%. The firm had revenue of $57.83 million for the quarter, compared to the consensus estimate of $58.60 million. On average, analysts expect Mesa Laboratories to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Mesa Laboratories Stock Down 1.4 %
MLAB opened at $140.47 on Monday. The stock has a market cap of $762.75 million, a price-to-earnings ratio of -3.08 and a beta of 0.82. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.51 and a current ratio of 0.70. The firm’s fifty day moving average is $128.76 and its 200 day moving average is $124.07. Mesa Laboratories has a fifty-two week low of $83.68 and a fifty-two week high of $149.50.
Mesa Laboratories Dividend Announcement
Analyst Ratings Changes
Several analysts recently issued reports on the company. StockNews.com cut Mesa Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, November 13th. Evercore ISI increased their price objective on shares of Mesa Laboratories from $120.00 to $160.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st.
Get Our Latest Research Report on MLAB
About Mesa Laboratories
Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.
Recommended Stories
- Five stocks we like better than Mesa Laboratories
- How to buy stock: A step-by-step guide for beginners
- MP Materials: Rare Earth Elements Powering the EV Boom
- Roth IRA Calculator: Calculate Your Potential Returns
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.